breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 2,621,984 | 0 | A | C | 61.5% | 6.2 / 10.3 | 13 | V105G (GTC→GGC) | pdeF | cyclic‑guanylate‑specific phosphodiesterase PdeF |
* | NZ_CP009273 | 2,033,562 | 0 | T | A | 58.3% | 2.2 / 11.0 | 12 | Y202N (TAT→AAT) | msrP | protein‑methionine‑sulfoxide reductase catalytic subunit MsrP |
* | NZ_CP009273 | 1,340,910 | 0 | C | A | 55.6% | 5.8 / 22.6 | 18 | L30F (TTG→TTT) | pdeR | cyclic di‑GMP phosphodiesterase |
* | NZ_CP009273 | 322,502 | 0 | C | G | 54.5% | 2.7 / 13.5 | 11 | G153R (GGC→CGC) | betA | choline dehydrogenase |
* | NZ_CP009273 | 612,012 | 0 | T | G | 54.5% | 4.7 / 11.0 | 11 | G800G (GGT→GGG) | entF | enterobactin non‑ribosomal peptide synthetase EntF |
* | NZ_CP009273 | 822,963 | 0 | T | G | 54.5% | ‑2.2 / 10.2 | 11 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |
* | NZ_CP009273 | 1,152,731 | 0 | T | A | 54.5% | 3.4 / 10.7 | 11 | L167I (TTA→ATA) | ycfH | metal‑dependent hydrolase |
* | NZ_CP009273 | 4,058,951 | 0 | G | C | 54.5% | 5.2 / 10.7 | 11 | A59G (GCG→GGG) | yihO | MFS transporter |
* | NZ_CP009273 | 765,675 | 0 | A | C | 53.8% | 8.5 / 12.2 | 13 | T748P (ACC→CCC) | mngB | mannosylglycerate hydrolase |
* | NZ_CP009273 | 4,290,979 | 0 | T | G | 53.3% | 13.2 / 16.1 | 15 | T639T (ACA→ACC) | mdtO | multidrug efflux transporter permease subunit MdtO |
* | NZ_CP009273 | 2,304,328 | 0 | A | C | 52.6% | 14.0 / 20.0 | 19 | V229G (GTA→GGA) | apbE | FAD:protein FMN transferase ApbE |
* | NZ_CP009273 | 3,126,661 | 0 | T | G | 52.6% | 6.5 / 24.7 | 19 | H219P (CAC→CCC) | yghS | dTMP kinase |
* | NZ_CP009273 | 4,098,337 | 0 | T | G | 52.6% | 19.4 / 24.4 | 19 | G286G (GGT→GGG) | pfkA | 6‑phosphofructokinase |
* | NZ_CP009273 | 3,659,062 | 0 | C | A | 44.0% | 33.5 / 14.7 | 25 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
* | NZ_CP009273 | 1,140,137 | 0 | G | . | 40.0% | 11.9 / 11.1 | 10 | intergenic (‑314/‑259) | rne/rluC | ribonuclease E/23S rRNA pseudouridine(955/2504/2580) synthase RluC |
* | NZ_CP009273 | 4,464,518 | 0 | C | A | 32.4% | 49.2 / 10.5 | 35 | T193N (ACT→AAT) | bdcR | TetR/AcrR family transcriptional regulator |
* | NZ_CP009273 | 4,431,979 | 0 | A | T | 23.3% | 105.1 / 10.0 | 43 | D5E (GAT→GAA) | msrA | peptide‑methionine (S)‑S‑oxide reductase MsrA |
Marginal new junction evidence (sorted from low to high skew) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP009273 | 4398991 = | 42 (2.120) | 3 (0.180) | 3/136 | 1.5 | 12.1% | intergenic (+79/‑101) | rnr/rlmB | ribonuclease R/23S rRNA (guanosine(2251)‑2'‑O)‑methyltransferase RlmB |
? | NZ_CP009273 | 4399052 = | 9 (0.550) | intergenic (+140/‑40) | rnr/rlmB | ribonuclease R/23S rRNA (guanosine(2251)‑2'‑O)‑methyltransferase RlmB |